Expert View
- Top intraday trading ideas for afternoon trade for Monday 18 February 2019
- Mentha oil prices rise on high demand
- Share market update: 254 stocks hit 52-week lows on NSE
- YES Bank drops 8% after RBI letter on RAR report
- Gold Rate Today: Gold, silver glitter on high demand, firm global trend
- Share market update: IT shares dip; Infibeam Avenues slips 4%
- Share market update: ADAG stocks surge; RCom, R Power jump upto 12%
- Investing in global companies can give you an edge: Saurabh Mukherjea
- Dewan Housing shares jump on stake sale report
CHOOSE LANGUAGE
ENG
- ENG - English
- HIN - हिन्दी
- GUJ - ગુજરાતી
- MAR - मराठी
- BEN - বাংলা
- KAN - ಕನ್ನಡ
- ORI - ଓଡିଆ
- TEL - తెలుగు
- TAM - தமிழ்
Prefer niche pharma cos to those in generic space: Devang Mehta, Centrum Wealth
We have stayed underweight on Sun Pharma, Lupin and Dr Reddy’s, says Mehta
We are sitting on the sidelines, not much churn is happening now: Chakri Lokapriya
There is no point selling because valuations look okay now, says Lokapriya.
During fiscal expansion, cutting rates aggressively will be adding fuel to fire: Krishna Memani, Oppenheimer Funds
"Corporate governance and leverage have been perennial issues in Indian corporate sector"
Market not pricing in earnings recovery for a few quarters: Jonathan Schiessl
"Emerging market space will continue to attract capital flow as against developed markets."
Corporate facing banks would top growth chart: Anand Tandon
If you are looking at value investing, certainly the index is not the place to be.
10,500-10,600 a strong support zone for Nifty: Kunal Bothra
REC and PFC have been doing extremely well even in a market which has become very volatile.
BULL'S EYE
MFs bought select IT, bank stocks in Jan ahead of Budget, May polls
January was the third straight month when inflows into equity funds slowed down.
Poll jitters make EM fund managers steer clear of Indian equities
The upcoming general election is a key event looming over the market.
Profit, sales growth for 4 straight quarters! 23 stocks that fit the bill
Tata Motors delivered a shock with its record loss for December quarter.
What to buy in this market? Stocks showing green shoots & the ones that are evergreen
These stocks can be considered for accumulation in 3-4 tranches.
What’s the right time to sell a stock? Jhunjhunwala has an answer
The ace investor said it is not that he keeps on buying a stock up to any valuation.
Promoter share pledges: Are all these 2,942 stocks untouchable?
Investors have become suspicious of every company, where promoter share pledge is high.
Gold prospects brighten amid brisk buying by the Chinese central bank
The yellow metal is expected to see some momentum this year.
Seven stocks where Prof Sanjay Bakshi’s Fund is betting on ‘moat’ to create value
Many of the stocks in Bakshi’s portfolio witnessed severe beating all through last year.
Top fund houses are busy lapping up PSUs; what’s behind this new-found love
PSU stocks have had a poor start to 2019, with BSE PSU Index falling 4.58 per cent in January.
Market Movers
Markets Videos
Only technicals matter; terrorist attack, upcoming elections are passing phases: Vivek Mavani
A huge amount of leverage built during the 2013-2018 bull market, is now unravelling, says Mavani.
Broader markets have seen 50%, 60% corrections which is a sign of bear market: Nitin Raheja
We are going to see a liquidity pressure as far as the markets are concerned, says Raheja.
In FY20,expecting 16-18% earnings growth for Nifty: Shibani Sircar Kurian, Kotak Mahindra AMC
Premiumisation as a theme is playing out in consumer stocks, says Kurian.
Dr Reddy’s heading for big trouble: Amit Rajan, Celogen Life Sciences
There are multiple problems ahead of Dr Reddy’s in coming days, says Rajan.
We are always looking at opportunities to enhance shareholder value: Amritanshu Khaitan, Eveready
As we scale up, the margins in lighting should improve substantially, says Khaitan.
New product launches will continue to drive growth: Glenn Saldanha, Glenmark
Our EBITDA margins continue to be about 17 plus per cent, says Glenmark Pharma CMD
Huge money waiting on sidelines for India, waiting for clarity on politics & liquidity: Madhav Dhar, GTI Capital
Money will come in as growth accelerates. India is still very much on people’s radar, says Dhar.
This pessimism is overdone; I have not seen such despondency in broader market in many years: Sanjiv Bhasin
Six months onwards, you will be making a lot of money in select stocks, says Bhasin
Investors are okay about taking a valuation risk but not earnings or governance risk: H Nemkumar, IIFL
Market sentiment is downbeat, fresh capital allocations unlikely before election, says Nemkumar.
Jet deal not clear about where cash to run operation will come from: Dhiraj Mathur, PwC
Converting debt into equity does not bring in any money into the company, says Mathur.
